| Authors: |
Hanscom B; Vaccine and Infectious Disease Division, Fred Hutch Cancer Center, Seattle, Washington, USA., Marzinke MA; John Hopkins School of Medicine, John Hopkins University, Baltimore, Maryland, USA., Li X; School of Pharmacy and Pharmaceutical Sciences, University of Buffalo, Buffalo, New York, USA., Donnell D; Vaccine and Infectious Disease Division, Fred Hutch Cancer Center, Seattle, Washington, USA., Bies R; School of Pharmacy and Pharmaceutical Sciences, University of Buffalo, Buffalo, New York, USA., Hendrix CW; John Hopkins School of Medicine, John Hopkins University, Baltimore, Maryland, USA., Wang Z; Vaccine and Infectious Disease Division, Fred Hutch Cancer Center, Seattle, Washington, USA., Acuipil C; ViiV Healthcare, Durham, North Carolina, USA., Rinehart A; ViiV Healthcare, Durham, North Carolina, USA., Collins JW; ViiV Healthcare, Durham, North Carolina, USA., Rooney JF; Gilead Sciences, Foster City, California, USA., Soto Torres L; NIH Division of AIDS, Bethesda, Maryland, USA., Richardson P; John Hopkins School of Medicine, John Hopkins University, Baltimore, Maryland, USA., Chariyalerstsak S; Department of Community Medicine, Chang Mai University, Chang Mai, Thailand., Valdez Ramalho Madruga J; Secretarial of Health, Sao Paulo, Brazil., Hurt CB; Institute for Global Health and Infectious Diseases, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina, USA., Magnus M; Milken Institute School of Public Health, George Washington University, Washington DC, USA., Frank I; Division of Infectious Diseases, University of Pennsylvania, Philadelphia, Pennsylvania, USA., McCauley M; Family Health International (FHI 360), Washington, DC, USA., Grinsztejn B; Evandro Chagas National Institute of Infectious Diseases-Oswaldo Cruz Foundation, Rio ds Janeiro, Brazil., Landovitz RJ; CARE Center, University of California Los Angeles, Los Angeles, California, USA. |
